Literature DB >> 19542630

Insulin is a two-edged knife on the brain.

Susana Cardoso1, Sónia Correia, Renato X Santos, Cristina Carvalho, Maria S Santos, Catarina R Oliveira, George Perry, Mark A Smith, Xiongwei Zhu, Paula I Moreira.   

Abstract

Insulin, long known as an important regulator of blood glucose levels, plays important and multifaceted roles in the brain. It has been reported that insulin is an important neuromodulator, contributing to several neurobiological processes in particular energy homeostasis and cognition. Dysregulation of insulin signaling has been linked to aging and metabolic and neurodegenerative disorders. The first part of this review is devoted to discussion of the critical role of insulin signaling in normal brain function. Then the involvement of impaired insulin signaling in the pathophysiology of diabetes, Alzheimer's, Parkinson's and Huntington's diseases and amyotrophic lateral sclerosis will be discussed. Finally, the potential therapeutic effect of insulin and insulin sensitizers will be examined.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542630     DOI: 10.3233/JAD-2009-1155

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  23 in total

Review 1.  Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

Authors:  Sónia C Correia; Renato X Santos; George Perry; Xiongwei Zhu; Paula I Moreira; Mark A Smith
Journal:  Ageing Res Rev       Date:  2011-01-22       Impact factor: 10.895

2.  Awake, long-term intranasal insulin treatment does not affect object memory, odor discrimination, or reversal learning in mice.

Authors:  Genevieve A Bell; Debra Ann Fadool
Journal:  Physiol Behav       Date:  2017-03-02

3.  Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes.

Authors:  Ying Liu; Fei Liu; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  J Pathol       Date:  2011-05-19       Impact factor: 7.996

4.  Nine-month follow-up of the insulin receptor signalling cascade in the brain of streptozotocin rat model of sporadic Alzheimer's disease.

Authors:  J Osmanovic Barilar; A Knezovic; E Grünblatt; P Riederer; M Salkovic-Petrisic
Journal:  J Neural Transm (Vienna)       Date:  2014-12-12       Impact factor: 3.575

5.  Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model.

Authors:  Xu Wang; Wei Zheng; Jing-Wei Xie; Tao Wang; Si-Ling Wang; Wei-Ping Teng; Zhan-You Wang
Journal:  Mol Neurodegener       Date:  2010-11-02       Impact factor: 14.195

Review 6.  Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.

Authors:  Rasoul Ghasemi; Leila Dargahi; Ali Haeri; Maryam Moosavi; Zahurin Mohamed; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2013-01-20       Impact factor: 5.590

Review 7.  Alzheimer's disease and type 2 diabetes: exploring the association to obesity and tyrosine hydroxylase.

Authors:  Medha Priyadarshini; Mohammad A Kamal; Nigel H Greig; Marcella Reale; Adel M Abuzenadah; Adeel G A Chaudhary; Ghazi A Damanhouri
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-06-01       Impact factor: 4.388

Review 8.  Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review.

Authors:  Erwin Lemche
Journal:  Curr Genomics       Date:  2018-11       Impact factor: 2.236

9.  Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults.

Authors:  Siobhan M Hoscheidt; Erika J Starks; Jennifer M Oh; Henrik Zetterberg; Kaj Blennow; Rachel A Krause; Carey E Gleason; Luigi Puglielli; Craig S Atwood; Cynthia M Carlsson; Sanjay Asthana; Sterling C Johnson; Barbara B Bendlin
Journal:  J Alzheimers Dis       Date:  2016-04-12       Impact factor: 4.472

Review 10.  The role of glucose transporters in brain disease: diabetes and Alzheimer’s Disease.

Authors:  Kaushik Shah; Shanal Desilva; Thomas Abbruscato
Journal:  Int J Mol Sci       Date:  2012-10-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.